Clinical Trials Browser

Phase 3 × OTHER × Pafolacianine × Clear all

NCT06915727 2025-10-08

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Phase 3 Recruiting

GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms